American Tungsten & Antimony raises $10M for US critical minerals
American Tungsten & Antimony (ASX:AT4) has secured $10 million through a firm share placement to accelerate its critical minerals strategy in the US.

Finance journalist at Grafa. Covers tech, crypto, and markets, making complex finance clear for all. Passionate about innovation and trends.
American Tungsten & Antimony (ASX:AT4) has secured $10 million through a firm share placement to accelerate its critical minerals strategy in the US.
ASX-listed global money transfer company OFX Group (ASX:OFX) reported a challenging financial year ended March 31.
Parkway (ASX:PWN) has executed a binding memorandum of understanding with technology firm Hitachi.
Federal budget trust tax hikes are forcing 350,000 Australian small businesses to restructure, triggering a massive state stamp duty crisis.
Bally’s Corp. (NYSE:BALY) reported a 28.3% surge in first-quarter revenue, hitting $755.7 million for the period ended March 31, 2026.
Design Therapeutics (NASDAQ:DSGN) announced positive biomarker and clinical findings from its ongoing Phase 1/2 RESTORE-FA clinical trial evaluating DT-216P2 in individuals with Friedreich ataxia (FA).
Ondas Holdings (NASDAQ:ONDS) has signed a definitive agreement to acquire 100% of Omnisys, an Israeli-based developer of advanced, AI-powered Battle Resource Optimization (BRO) software.
Functional Brands (NASDAQ:MEHA) reported its financial results for the first quarter ended March 31, 2026, delivering top-line growth and a notable expansion in product margins alongside a series of digital and corporate transitions.
Pioneer Power Solutions (NASDAQ:PPSI) reported its financial results for the first quarter ended March 31, 2026, highlighting a substantial improvement in manufacturing margins and an expanding order backlog, despite a cyclical contraction in quarterly revenue.
Compugen (NASDAQ:CGEN) reported a net loss for the first quarter of 2026, alongside a stable cash position expected to sustain its clinical-stage pipeline into 2029.